Agalsidase beta

Active ingredient description

Agalsidase beta is a recombinant form of human α-galactosidase A and is produced by recombinant DNA technology using a mammalian Chinese Hamster Ovary (CHO) cell culture. The amino acid sequence of the recombinant form, as well as the nucleotide sequence which encoded it, are identical to the natural form of α-galactosidase.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Agalsidase beta
A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AB Enzymes
Discover more medicines within A16AB04

Medicines

Agalsidase beta is the active ingredient of these drugs:

Drug
Countries

Austria Brazil Canada Cyprus Ecuador

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)

External identifiers

CAS Substance: 104138-64-9
DrugBank Drug: DB00103
RxNorm Ingredient: 338817
SNOMED-CT Concept: 424725004
Agalsidase beta (substance)
UNII Identifier: RZD65TSM9U
AGALSIDASE BETA